Page last updated: 2024-10-28

guaifenesin and Diabetes Mellitus, Type 2

guaifenesin has been researched along with Diabetes Mellitus, Type 2 in 3 studies

Guaifenesin: An expectorant that also has some muscle relaxing action. It is used in many cough preparations.

Diabetes Mellitus, Type 2: A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (33.33)24.3611
2020's2 (66.67)2.80

Authors

AuthorsStudies
Aggarwal, V1
Sunder, S1
Verma, SR1
Shi, Y1
Liu, L1
Yin, M1
Zhao, Z1
Liang, Y1
Sun, K1
Li, Y1
Sintsova, O1
Gladkikh, I1
Kalinovskii, A1
Zelepuga, E1
Monastyrnaya, M1
Kim, N1
Shevchenko, L1
Peigneur, S1
Tytgat, J1
Kozlovskaya, E1
Leychenko, E1

Reviews

1 review available for guaifenesin and Diabetes Mellitus, Type 2

ArticleYear
Disease-associated dysbiosis and potential therapeutic role of Akkermansia muciniphila, a mucus degrading bacteria of gut microbiome.
    Folia microbiologica, 2022, Volume: 67, Issue:6

    Topics: COVID-19; Diabetes Mellitus, Type 2; Dysbiosis; Gastrointestinal Microbiome; Humans; Mucins; Mucus;

2022

Other Studies

2 other studies available for guaifenesin and Diabetes Mellitus, Type 2

ArticleYear
Mucus- and pH-mediated controlled release of core-shell chitosan nanoparticles in the gastrointestinal tract for diabetes treatment.
    Journal of drug targeting, 2023, Volume: 31, Issue:1

    Topics: Administration, Oral; Animals; Chitosan; Delayed-Action Preparations; Diabetes Mellitus, Type 2; Dru

2023
Magnificamide, a β-Defensin-Like Peptide from the Mucus of the Sea Anemone
    Marine drugs, 2019, Sep-21, Volume: 17, Issue:10

    Topics: alpha-Amylases; Amino Acid Sequence; Animals; beta-Defensins; Blood Glucose; Cnidarian Venoms; Diabe

2019